SCHEMBL18778142

SCHEMBL18778142

c1ccc(-n2c3ccccc3c3cc(-c4cccc(-c5cccc(-c6cccc(-c7ccc(-c8cnc9c%10ccccc%10c%10ccccc%10c9n8)cc7)c6)c5)c4)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PTGER4 P35408 1/20 0.35
TSPO P30536 1/20 0.34
ATR Q13535 1/20 0.33
NPY5R Q15761 1/20 0.32
NOS1 P29475 2/20 0.32
NR3C1 P04150 1/20 0.32
HDAC4 P56524 1/20 0.32
KMT2A Q03164 1/20 0.32
IL1R1 P14778 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18778038 1.00 KDM4E (0.41) KDM4EATML3MBTL1PTGER4TSPO
SCHEMBL18778091 1.00 KDM4E (0.41) KDM4EATML3MBTL1PTGER4TSPO
SCHEMBL18778084 1.00 KDM4E (0.41) KDM4EATML3MBTL1PTGER4TSPO
SCHEMBL12268699 1.00 KDM4E (0.41) KDM4EATML3MBTL1PTGER4TSPO
SCHEMBL18778087 1.00 KDM4E (0.41) KDM4EATML3MBTL1PTGER4TSPO
SCHEMBL18778003 1.00 KDM4E (0.41) KDM4EATML3MBTL1PTGER4TSPO
SCHEMBL18778137 1.00 KDM4E (0.41) KDM4EATML3MBTL1PTGER4TSPO
SCHEMBL18778349 1.00 KDM4E (0.41) KDM4EATML3MBTL1PTGER4TSPO
SCHEMBL18778139 1.00 KDM4E (0.41) KDM4EATML3MBTL1PTGER4TSPO
SCHEMBL18778315 1.00 KDM4E (0.41) KDM4EATML3MBTL1PTGER4TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11522138-B2 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2022-12-06 US disclosed
US-20170117487-A1 Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-04-27 US disclosed
US-20170117487-A1 Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170117487-A1 Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device RECQL, HSF1, DDX41 KDM4E 2319/4885ATM 1948/4885L3MBTL1 1123/4885
US-11522138-B2 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device RECQL, HSF1, DDX41 KDM4E 2319/4885ATM 1948/4885L3MBTL1 1123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.